TY - JOUR T1 - Melatonin: prescribing practices and adverse events JF - Archives of Disease in Childhood JO - Arch Dis Child SP - 1206 LP - 1207 DO - 10.1136/adc.2005.077289 VL - 90 IS - 11 AU - D L Waldron AU - D Bramble AU - P Gringras Y1 - 2005/11/01 UR - http://adc.bmj.com/content/90/11/1206.abstract N2 - Melatonin is currently an unlicensed, “named patient only” medicine in the UK, although it is available as a dietary supplement in the United States and over the internet. It is used for a variety of sleep disorders in children who often have neurodevelopmental impairments.1,2 There remains a dearth of robust randomised controlled trials to demonstrate its efficacy, while lack of pharmacokinetic, pharmacodynamics, and toxicology data limits knowledge of therapeutic dose ranges, formulations, and adverse effects.We carried out an anonymous questionnaire survey to examine prescribing practices of members of the British Association for Community Child Health (BACCH) and the British Academy of … ER -